Estados Unidos - inglês - NLM (National Library of Medicine)

pfizer laboratories div pfizer inc - thrombin (unii: 25ade2236l) (thrombin - unii:25ade2236l) - thrombin 5000 [iu] in 5 ml - thrombin-jmi is topical bovine thrombin indicated to aid hemostasis whenever oozing blood and minor bleeding from capillaries and small venules is accessible and control of bleeding by standard surgical techniques (such as suture, ligature, or cautery) is ineffective or impractical. in various types of surgeries, solutions of thrombin-jmi may be used in conjunction with an absorbable gelatin sponge, usp for hemostasis.       risk summary animal reproduction studies have not been conducted with thrombin-jmi. it is also not known whether thrombin-jmi can cause fetal harm when administered to a pregnant woman. thrombin-jmi should be given to a pregnant woman only if clearly needed. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

octapharma limited - human coagulation factor ii, human coagulation factor vii, human coagulation factor ix, human coagulation factor x, protein c, protein s - pdr+solv for soln for inf - 1000 international unit - blood coagulation factors

Canadá - inglês - Health Canada

omrix biopharmaceuticals ltd - fibrinogen (human); thrombin (human) - solution - 90mg; 1200unit - fibrinogen (human) 90mg; thrombin (human) 1200unit - hemostatics

Malta - inglês - Malta Medicines Authority

baxalta innovations gmbh industriestrasse 67, 1221, vienna, austria - antithrombin iii - powder and solvent for solution for infusion or injection - antithrombin iii 50 iu - antithrombotic agents

Malta - inglês - Malta Medicines Authority

baxalta innovations gmbh industriestrasse 67, 1221, vienna, austria - antithrombin iii - powder and solvent for solution for infusion or injection - antithrombin iii 50 iu/ml - antithrombotic agents

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

baxalta innovations gmbh - human coagulation factor ii; human coagulation factor vii; human coagulation factor ix; human coagulation factor x; human protein c - powder and solvent for solution for injection - coagulation factor ix, ii, vii and x in combination

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

csl behring gmbh - human fibrinogen - powder for solution for injection/infusion - 1 gram(s) - fibrinogen; fibrinogen, human

Canadá - inglês - Health Canada

takeda canada inc - antithrombin iii (human) - kit - 1100unit - antithrombin iii (human) 1100unit - direct thrombin inhibitors

Canadá - inglês - Health Canada

takeda canada inc - antithrombin iii (human) - kit - 550unit - antithrombin iii (human) 550unit - direct thrombin inhibitors

Estados Unidos - inglês - NLM (National Library of Medicine)

mallinckrodt hospital products inc. - thrombin alfa (unii: sck81amr7r) (thrombin alfa - unii:sck81amr7r) - thrombin alfa 1000 [iu] in 1 ml - recothrom® thrombin topical (recombinant), is a topical thrombin indicated to aid hemostasis whenever oozing blood and minor bleeding from capillaries and small venules is accessible and control of bleeding by standard surgical techniques (such as suture, ligature, or cautery) is ineffective or impractical in adults and pediatric populations greater than or equal to one month of age. recothrom may be used in conjunction with an absorbable gelatin sponge, usp. - do not inject directly into the circulatory system. - do not use for the treatment of massive or brisk arterial bleeding. - do not administer to patients with a history of hypersensitivity to recothrom or any components of recothrom. - do not use in patients with known hypersensitivity to hamster proteins. pregnancy category c animal reproduction studies have not been conducted with recothrom. it is also not known whether recothrom can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. recothrom should be given